Lipid droplets-related Perilipin-3: potential immune checkpoint and oncogene in oral squamous cell carcinoma

被引:3
作者
He, Yijia [1 ]
Liu, Lingyun [1 ]
Dong, Yuexin [1 ]
Zhang, Xiaoxin [1 ]
Song, Yuxian [1 ]
Jing, Yue [1 ]
Ni, Yanhong [1 ]
Wang, Yi [2 ]
Wang, Zhiyong [2 ]
Ding, Liang [1 ]
机构
[1] Nanjing Univ, Nanjing Stomatol Hosp, Med Sch, Cent Lab Stomatol,Affiliated Hosp, Nanjing, Peoples R China
[2] Nanjing Univ, Nanjing Stomatol Hosp, Affiliated Hosp, Dept Oral & Maxillofacial Surg,Med Sch, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
OSCC; Lipid droplets; Perilipin-3; PD-L1; B7-H2; ADIPOPHILIN EXPRESSION; PROTEINS; GROWTH;
D O I
10.1007/s00262-024-03659-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Lipid droplets (LDs) as major lipid storage organelles are recently reported to be innate immune hubs. Perilipin-3 (PLIN3) is indispensable for the formation and accumulation of LDs. Since cancer patients show dysregulated lipid metabolism, we aimed to elaborate the role of LDs-related PLIN3 in oral squamous cell carcinoma (OSCC).Methods PLIN3 expression patterns (n = 87), its immune-related landscape (n = 74) and association with B7-H2 (n = 51) were assessed by immunohistochemistry and flow cytometry. Real-time PCR, Western blot, Oil Red O assay, immunofluorescence, migration assay, spheroid-forming assay and flow cytometry were performed for function analysis.Results Spotted LDs-like PLIN3 staining was dominantly enriched in tumor cells than other cell types. PLIN3high tumor showed high proliferation index with metastasis potential, accompanied with less CD3+CD8+ T cells in peripheral blood and in situ tissue, conferring immunosuppressive microenvironment and shorter postoperative survival. Consistently, PLIN3 knockdown in tumor cells not only reduced LD deposits and tumor migration, but benefited for CD8+ T cells activation in co-culture system with decreased B7-H2. An OSCC subpopulation harbored PLIN3highB7-H2high tumor showed more T cells exhaustion, rendering higher risk of cancer-related death (95% CI 1.285-6.851).Conclusions LDs marker PLIN3 may be a novel immunotherapeutic target in OSCC.
引用
收藏
页数:16
相关论文
共 45 条
  • [1] Cancer Focus Lipid metabolism and cancer
    Bian, Xueli
    Liu, Rui
    Meng, Ying
    Xing, Dongming
    Xu, Daqian
    Lu, Zhimin
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (01)
  • [2] The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment
    Bolandi, Nadia
    Derakhshani, Afshin
    Hemmat, Nima
    Baghbanzadeh, Amir
    Asadzadeh, Zahra
    Afrashteh Nour, Mina
    Brunetti, Oronzo
    Bernardini, Renato
    Silvestris, Nicola
    Baradaran, Behzad
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [3] Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense
    Bosch, Marta
    Sanchez-Alvarez, Miguel
    Fajardo, Alba
    Kapetanovic, Ronan
    Steiner, Bernhard
    Dutra, Filipe
    Moreira, Luciana
    Antonio Lopez, Juan
    Campo, Rocio
    Mari, Montserrat
    Morales-Paytuvi, Frederic
    Tort, Olivia
    Gubern, Albert
    Templin, Rachel M.
    Curson, James E. B.
    Martel, Nick
    Catala, Cristina
    Lozano, Francisco
    Tebar, Francesc
    Enrich, Carlos
    Vazquez, Jesus
    Del Pozo, Miguel A.
    Sweet, Matthew J.
    Bozza, Patricia T.
    Gross, Steven P.
    Parton, Robert G.
    Pol, Albert
    [J]. SCIENCE, 2020, 370 (6514) : 309 - +
  • [4] NCCN Guidelines® Insights Head and Neck Cancers, Version 1.2018 Featured Updates to the NCCN Guidelines
    Colevas, A. Dimitrios
    Yom, Sue S.
    Pfister, David G.
    Spencer, Sharon
    Adelstein, David
    Adkins, Douglas
    Brizel, David M.
    Burtness, Barbara
    Busse, Paul M.
    Caudell, Jimmy J.
    Cmelak, Anthony J.
    Eisele, David W.
    Fenton, Moon
    Foote, Robert L.
    Gilbert, Jill
    Gillison, Maura L.
    Haddad, Robert I.
    Hicks, Wesley L., Jr.
    Hitchcock, Ying J.
    Jimeno, Antonio
    Leizman, Debra
    Maghami, Ellie
    Mell, Loren K.
    Mittal, Bharat B.
    Pinto, Harlan A.
    Ridge, John A.
    Rocco, James
    Rodriguez, Cristina P.
    Shah, Jatin P.
    Weber, Randal S.
    Witek, Matthew
    Worden, Frank
    Zhen, Weining
    Burns, Jennifer L.
    Darlow, Susan D.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (05): : 479 - 490
  • [5] Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance
    Cotte, Alexia Karen
    Aires, Virginie
    Fredon, Maxime
    Limagne, Emeric
    Derangere, Valentin
    Thibaudin, Marion
    Humblin, Etienne
    Scagliarini, Alessandra
    de Barros, Jean-Paul Pais
    Hillon, Patrick
    Ghiringhelli, Francois
    Delmas, Dominique
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [6] Lipid droplets: platforms with multiple functions in cancer hallmarks
    Cruz, Andre L. S.
    Barreto, Ester de A.
    Fazolini, Narayana P. B.
    Viola, Joao P. B.
    Bozza, Patricia T.
    [J]. CELL DEATH & DISEASE, 2020, 11 (02)
  • [7] RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-κB pathway in oral squamous cell carcinoma
    Dan, Hongxia
    Liu, Sai
    Liu, Jiajia
    Liu, Dongjuan
    Yin, Fengying
    Wei, Zihao
    Wang, Jiongke
    Zhou, Yu
    Jiang, Lu
    Ji, Ning
    Zeng, Xin
    Li, Jing
    Chen, Qianming
    [J]. MOLECULAR ONCOLOGY, 2020, 14 (04) : 795 - 807
  • [8] Lipid Droplets as Immune Modulators in Myeloid Cells
    den Brok, Martijn H.
    Raaijmakers, Tonke K.
    Collado-Camps, Estel
    Adema, Gosse J.
    [J]. TRENDS IN IMMUNOLOGY, 2018, 39 (05) : 380 - 392
  • [9] OXTRHigh stroma fibroblasts control the invasion pattern of oral squamous cell carcinoma via ERK5 signaling
    Ding, Liang
    Fu, Yong
    Zhu, Nisha
    Zhao, Mengxiang
    Ding, Zhuang
    Zhang, Xiaoxin
    Song, Yuxian
    Jing, Yue
    Zhang, Qian
    Chen, Sheng
    Huang, Xiaofeng
    O'Reilly, Lorraine A.
    Silke, John
    Hu, Qingang
    Ni, Yanhong
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [10] The balance of serum IL-18/IL-37 levels is disrupted during the development of oral squamous cell carcinoma
    Ding, Liang
    Zhao, Xingxing
    Zhu, Nisha
    Zhao, Mengxiang
    Hu, Qingang
    Ni, Yanhong
    [J]. SURGICAL ONCOLOGY-OXFORD, 2020, 32 : 99 - 107